Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with FDA approval for subcutaneous use. The LIBerate Program showed sustained ...

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Self-medicating with vitamin B12 without a doctor’s guidance is not a good idea. Even though B12 is water-soluble (meaning excess amounts are usually flushed out in urine), taking more than your body ...

A global trial has suggested that a monthly injection could allow people with severe asthma to stop taking daily steroid tablets altogether or at least reduce their intake, with no ill effects. More ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

Most of us understand that our bodies require a variety of vitamins and nutrients to function optimally. We typically obtain these essential vitamins from our diet, but occasionally, deficiencies can ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...

Novo Nordisk, a Who's Who in the pharmaceutical industry, has now made public that it has officially launched, for medical use, its blockbuster diabetes medication, Ozempic (Semaglutide), in India.

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks. Ozempic-- a once-weekly injectable formulation of semaglutide -- is ...

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...